Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Editorial

Published on 11 Jun 2024

Editorial: Editor's challenge: Dr. Qingxin Mu - how can nanomedicine approaches advance multi-targeting strategy in combination cancer therapy?

in Cancer Molecular Targets and Therapeutics

Marina Pinheiro
Qingxin Mu

Frontiers in Oncology

doi 10.3389/fonc.2024.1437497

518 views

Case Report

Published on 10 Jun 2024

Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden

in Cancer Molecular Targets and Therapeutics

Rebekka Mispelbaum
Tessa Hattenhauer
Franz-Georg Bauernfeind
Jan-Frederic Lau
Peter Brossart
Annkristin Heine

Frontiers in Oncology

doi 10.3389/fonc.2024.1406616

865 views
1 citation

Brief Research Report

Published on 30 May 2024

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer

in Cancer Molecular Targets and Therapeutics

Andrew Takchi
Minzhi Zhang
Mohammad Jalalirad
Roberto Leon Ferre
Royal Shrestha
Tufia Haddad
Jann Sarkaria
Ann Tuma
Jodi Carter
Hillman David

Frontiers in Oncology

doi 10.3389/fonc.2024.1384277

2,057 views

Mini Review

Published on 28 May 2024

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?

in Cancer Molecular Targets and Therapeutics

Fengqin Liu
Xia Miao
Lu Han
Xiao Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1390006

2,979 views
1 citation

Review

Published on 28 May 2024

Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies

in Cancer Molecular Targets and Therapeutics

Nating Xiong
Heming Wu
Zhikang Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1405491

6,740 views
4 citations

Perspective

Published on 24 May 2024

Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group

in Cancer Molecular Targets and Therapeutics

Nam P. Nguyen
Monica-Emilia Chirila
Brandi R. Page
Vincent Vinh-Hung
Olena Gorobets
Mohammad Mohammadianpanah
Huan Giap
Meritxell Arenas
Marta Bonet
Pedro Carlos Lara

Frontiers in Oncology

doi 10.3389/fonc.2024.1391464

1,854 views

Editorial

Published on 23 May 2024

Editorial: Novel therapeutic targets of gastric carcinogenesis: from basic research to drug development and clinical application

in Cancer Molecular Targets and Therapeutics

Chenchen Niu
Dong Ren
Bella Lingjia Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1431520

537 views

Mini Review

Published on 22 May 2024

Structural perspectives on recent breakthrough efforts toward direct drugging of RAS and acquired resistance

in Cancer Molecular Targets and Therapeutics

Jameela Lokhandwala
Tracess B. Smalley
Timothy H. Tran

Frontiers in Oncology

doi 10.3389/fonc.2024.1394702

3,992 views
3 citations

Original Research

Published on 17 May 2024

The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapy

in Cancer Molecular Targets and Therapeutics

Priya U. Kumthekar
Barbara Blouw
Perry Corkos
Seema Nagpal
Arushi Tripathy
David Piccioni
Michael Youssef

Frontiers in Oncology

doi 10.3389/fonc.2024.1402651

1,119 views
2 citations

Systematic Review

Published on 16 May 2024

Evolution and impact of molecular glue research: a bibliometric analysis from 2000 to 2023

in Cancer Molecular Targets and Therapeutics

Dian Li
Jingyi Cheng
Zhigen Yuan
Kexin Deng

Frontiers in Oncology

doi 10.3389/fonc.2024.1401257

2,128 views

Retraction

Published on 14 May 2024

Retraction: Exosomes derived from microRNA-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression

in Cancer Molecular Targets and Therapeutics

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2024.1422567

751 views

Original Research

Published on 14 May 2024

Efficacy and safety of anlotinib in patients with desmoid fibromatosis: a retrospective analysis

in Cancer Molecular Targets and Therapeutics

Mengzhang Xie
Qi Huang
Taojun Gong
Yitian Wang
Zhuangzhuang Li
Minxun Lu
Yi Luo
Li Min
Yong Zhou
Chongqi Tu

Frontiers in Oncology

doi 10.3389/fonc.2024.1399574

1,262 views
1 citation

Original Research

Published on 13 May 2024

Chloroquine-induced DNA damage synergizes with DNA repair inhibitors causing cancer cell death

in Cancer Molecular Targets and Therapeutics

Diego Iglesias-Corral
Paula García-Valles
Nuria Arroyo-Garrapucho
Elena Bueno-Martínez
Juan Manuel Ruiz-Robles
María Ovejero-Sánchez
Rogelio González-Sarmiento
Ana Belén Herrero

Frontiers in Oncology

doi 10.3389/fonc.2024.1390518

2,122 views
1 citation

Review

Published on 10 May 2024

Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment

in Cancer Molecular Targets and Therapeutics

Szu-Aun Long
Amber M. Amparo
Grace Goodhart
Syed A. Ahmad
Andrew M. Waters

Frontiers in Oncology

doi 10.3389/fonc.2024.1402128

5,936 views
2 citations

Review

Published on 10 May 2024

The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies

in Cancer Molecular Targets and Therapeutics

Oluwaseun Adebayo Bamodu
Chen-Chih Chung
Thomas R. Pisanic
Alexander T. H. Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1404628

1,521 views

Review

Published on 08 May 2024

The use of photodynamic therapy in medical practice

in Cancer Molecular Targets and Therapeutics

David Aebisher
Kacper Rogóż
Angelika Myśliwiec
Klaudia Dynarowicz
Rafał Wiench
Grzegorz Cieślar
Aleksandra Kawczyk-Krupka
Dorota Bartusik-Aebisher

Frontiers in Oncology

doi 10.3389/fonc.2024.1373263

3,875 views
7 citations

Navigation group

Articles

Editorial: Editor's challenge: Dr. Qingxin Mu - how can nanomedicine approaches advance multi-targeting strategy in combination cancer therapy?

Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?

Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies

Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group

Editorial: Novel therapeutic targets of gastric carcinogenesis: from basic research to drug development and clinical application

Structural perspectives on recent breakthrough efforts toward direct drugging of RAS and acquired resistance

The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapy

Evolution and impact of molecular glue research: a bibliometric analysis from 2000 to 2023

Retraction: Exosomes derived from microRNA-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression

Efficacy and safety of anlotinib in patients with desmoid fibromatosis: a retrospective analysis

Chloroquine-induced DNA damage synergizes with DNA repair inhibitors causing cancer cell death

Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment

The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies

The use of photodynamic therapy in medical practice